Ophthalmology

Top Story

Glucose metabolism affects macular thickness in diabetic patients

May 2, 2016

SEATTLE — Pericentral macular thickness decreased in diabetic patients with worsening glucose metabolism, which may reflect early neurodegenerative changes, according to a poster presented here.

“Macular thinning may be an early sign of diabetic retinopathy and macular thickening may be a sign of diabetic macular edema,” Eline E. De Clerck, MD, and colleagues said in the poster at the Association for Research in Vision and Ophthalmology meeting. “We therefore evaluated to what extent macular thickness differed between individuals with prediabetes and individuals with type 2 diabetes with or without cysts compared with individuals with a normal glucose metabolism.”

Meeting News CoverageFrom OSN Europe

Zeiss receives CE mark for PLEX Elite 9000 swept-source OCT system

May 2, 2016
SEATTLE — The Zeiss PLEX Elite 9000, a novel swept-source optical coherence tomography platform, has received CE mark approval in the European Union, Carl Zeiss…
Meeting News CoverageVideo

VIDEO: LALES study shows need for early AMD intervention for Latino population in US

May 1, 2016
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Grace Richter, MD, of the USC Roski Eye Institute, discusses key takeaways from the Los…
Meeting News CoverageVideo

VIDEO: Retina World Congress aims to create true global collaboration

May 1, 2016
SEATTLE — At an informational event during the Association for Research in Vision and Ophthalmology meeting, leaders of the Retina…
Meeting News Coverage

Anti-VEGF effective in wet AMD, diabetic retinopathy

May 1, 2016
SEATTLE — Patients diagnosed with both neovascular age-related macular degeneration and diabetic retinopathy who received intravitreal injections showed…
More News Headlines »
Clinical Science

Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema

Ophthalmic Surgery, Lasers and Imaging Retina, April 2016, Volume 47 Issue 4
The diabetic macular edema (DME) treatment paradigm has evolved as the understanding of the disease pathology has…
More »
CME

Emerging Options for Day-in and Day-out IOP Control

This activity is supported by an educational grant from Bausch + Lomb.

Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still…
More »
Featured
Highlights from ARVO

Highlights from ARVO

Video
Meeting News Coverage

VIDEO: Retina World Congress aims to create true global collaboration

May 1, 2016
More »
morganatic-roan